Related Experiment Video
Updated: Aug 5, 2026
Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
In vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells
M Kavallaris1, M Gardaneh, B Cheung
1Children's Cancer Research Institute, Sydney Children's Hospital, Randwick, Australia.
Abstract:
Amplification of the MYCN oncogene is a strong predictor of treatment failure and chemo-resistance in childhood neuroblastoma. Stable expression of two partial MYCN gene fragments in antisense orientation reduced Mycn protein expression in an MYCN-amplified neuroblastoma tumor cell line, however, antisense cells did not exhibit an increased in vitro sensitivity to cytotoxic or differentiating agents. In contrast, partial MYCN sense transfectants exhibited increased resistance to cytotoxic drugs. These data suggest that the chemo-resistance of MYCN-amplified neuroblastoma cells is complex, and may be due to factors additional to Mycn protein expression.
Insights
MYCN gene amplification in neuroblastoma predicts treatment failure. Reducing Mycn protein did not improve chemotherapy sensitivity, suggesting chemo-resistance involves factors beyond Mycn expression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MYCN oncogene amplification is a key driver of neuroblastoma aggressiveness.
- It strongly correlates with treatment failure and chemo-resistance in pediatric neuroblastoma.
- Understanding MYCN's role is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the functional role of Mycn protein levels in neuroblastoma chemo-resistance.
- To determine if reducing Mycn expression sensitizes neuroblastoma cells to chemotherapy.
- To explore the complexity of chemo-resistance mechanisms in MYCN-amplified neuroblastoma.
Main Methods:
- Stable expression of MYCN gene fragments in antisense and sense orientations in a neuroblastoma cell line.
- Assessment of Mycn protein levels following gene fragment expression.
- Evaluation of in vitro sensitivity to cytotoxic and differentiating agents in transfected cells.
Main Results:
- Antisense MYCN transfectants showed reduced Mycn protein expression but no increased sensitivity to cytotoxic or differentiating agents.
- Sense MYCN transfectants exhibited enhanced resistance to cytotoxic drugs.
- These findings indicate Mycn protein level reduction alone does not overcome chemo-resistance.
Conclusions:
- Neuroblastoma chemo-resistance is multifactorial and not solely dependent on Mycn protein levels.
- MYCN amplification's impact on chemo-resistance may involve complex regulatory pathways.
- Further research is needed to identify additional factors contributing to treatment failure in MYCN-amplified neuroblastoma.
